Clorox Co (NYSE:CLX) Stock Position Raised by Pictet Asset Management Ltd.

Pictet Asset Management Ltd. increased its holdings in shares of Clorox Co (NYSE:CLX) by 424.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 338,610 shares of the company’s stock after acquiring an additional 274,037 shares during the quarter. Pictet Asset Management Ltd. owned approximately 0.27% of Clorox worth $51,845,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. BlackRock Inc. grew its position in Clorox by 0.8% in the 1st quarter. BlackRock Inc. now owns 10,639,351 shares of the company’s stock worth $1,707,189,000 after purchasing an additional 83,514 shares during the last quarter. Parnassus Investments CA grew its holdings in Clorox by 2.9% in the 2nd quarter. Parnassus Investments CA now owns 4,634,090 shares of the company’s stock worth $709,526,000 after buying an additional 128,886 shares in the last quarter. Northern Trust Corp grew its holdings in Clorox by 0.6% in the 2nd quarter. Northern Trust Corp now owns 2,369,859 shares of the company’s stock worth $362,850,000 after buying an additional 14,792 shares in the last quarter. Geode Capital Management LLC increased its position in Clorox by 21.5% in the 4th quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after acquiring an additional 335,835 shares during the period. Finally, Janus Henderson Group PLC increased its position in Clorox by 1.9% in the 2nd quarter. Janus Henderson Group PLC now owns 1,804,217 shares of the company’s stock valued at $276,243,000 after acquiring an additional 33,032 shares during the period. Hedge funds and other institutional investors own 78.20% of the company’s stock.

In other news, Director A D. David Mackay sold 3,400 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Diego J. Barral sold 1,987 shares of the firm’s stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $157.59, for a total transaction of $313,131.33. The disclosure for this sale can be found here. Over the last quarter, insiders sold 15,609 shares of company stock worth $2,497,443. 1.40% of the stock is owned by company insiders.

A number of brokerages have issued reports on CLX. ValuEngine lowered Clorox from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. UBS Group lifted their price objective on shares of Clorox from $110.00 to $128.00 and gave the company a “sell” rating in a research note on Friday, August 2nd. Citigroup set a $156.00 price objective on shares of Clorox and gave the company a “hold” rating in a research note on Thursday, May 23rd. Argus downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Monday, May 20th. Finally, Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 target price for the company in a research report on Monday, July 29th. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. Clorox has an average rating of “Hold” and an average price target of $154.07.

NYSE CLX traded down $0.34 on Wednesday, reaching $157.94. 28,497 shares of the stock traded hands, compared to its average volume of 872,264. Clorox Co has a 12 month low of $141.53 and a 12 month high of $167.70. The company has a market cap of $19.86 billion, a price-to-earnings ratio of 24.99, a P/E/G ratio of 4.99 and a beta of 0.38. The firm’s fifty day simple moving average is $159.98 and its 200 day simple moving average is $156.22. The company has a quick ratio of 0.55, a current ratio of 0.91 and a debt-to-equity ratio of 4.09.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.04. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The business had revenue of $1.63 billion during the quarter, compared to analyst estimates of $1.69 billion. During the same quarter in the prior year, the firm posted $1.66 earnings per share. The company’s revenue was down 3.8% on a year-over-year basis. As a group, equities research analysts forecast that Clorox Co will post 6.4 EPS for the current fiscal year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: Fundamental Analysis – How It Helps Investors

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.